// App-Quantinova.ai

523 : The Development of the Ranked Composite Important Difference in Diffuse Cutaneous Systemic Sclerosis; A Clinical and Patient Meaningful Anchor to the ACR-Composite Response Index in SSc

Researchers

Presenter

  • Francesco Del Galdo

Principal Investigators

  • Lesley-Anne Bissell

  • Daniel Furst

  • sindhu johnson

  • Paul hansen

  • Esmeralda Recalde

  • Dinesh Khanna

Medical Centers

  • University of Leeds, Leeds, United Kingdom

  • University of California, Los Angeles, Los Angeles, CA

  • Division of Rheumatology, Department of Medicine, Toronto Western Hospital, Mount Sinai Hospital; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada

  • University of Otago, Dunedin, New Zealand

  • World Scleroderma Foundation, Florence, Italy

  • Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, United States.

  • Leeds Institute of Rheumatic and Musculoskeletal Medicine and NIHR-Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, Leeds, United Kingdom

Locations

  • United Kingdom

  • United States

  • Canada

  • New Zealand

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

  • Autoimmune (AI)

  • Genetic Disorder

Disease

  • Scleroderma

  • Mental retardation, X-linked, syndromic, 15

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Adaptive

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved